PQNT0.260%
as of Sep 1
SGP
GrowthSpyGlass Pharma, Inc.
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost.
Close · 3M
+23.26%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals2
Win rate100% (2/2)
Avg buy return+42.94%
PQNT · Weight decrease · 2d
weight 0.280% → 0.260% (-0.020 pp)·stock up 16.3% in the 30 days before
Aug 30·entry $26.10·now $28.99
+11.07%
since Aug 30
PQNT · Weight decrease · 2d
weight 0.320% → 0.290% (-0.030 pp)·stock up 15.7% in the 30 days before
Aug 2·entry $22.68·now $28.99
+27.82%
since Aug 2
PQNT · Weight increase · 2d
weight 0.300% → 0.320% (+0.020 pp)·stock up 15.7% in the 30 days before
Jul 31·entry $22.53·now $28.99Chased
+28.67%
since Jul 31
PQNT · Weight decrease · 2d
weight 0.340% → 0.310% (-0.030 pp)·stock up 4.3% in the 30 days before
Jul 2·entry $19.15·now $28.99
+51.38%
since Jul 2
PQNT · Weight increase · 2d
weight 0.410% → 0.430% (+0.020 pp)·stock down 22.6% in the 30 days before
Jun 12·entry $18.44·now $28.99Chased
+57.21%
since Jun 12
PQNT · Weight decrease · 2d
weight 0.440% → 0.400% (-0.040 pp)·stock down 20.2% in the 30 days before
Jun 4·entry $19.47·now $28.99
+48.90%
since Jun 4
PQNT · Weight decrease · 2d
weight 0.470% → 0.450% (-0.020 pp)·stock down 5.3% in the 30 days before
Apr 29·entry $22.13·now $28.99
+31.00%
since Apr 29
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.